PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 11644992

Was the UK collaborative ECMO trial ethical?

John D Lantos
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Biomedical TechnologyCoercionCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesCritical IllnessExtracorporeal Membrane OxygenationHuman ExperimentationHumansInfant, NewbornInternational CooperationInternationalityMortalityParental ConsentPatient CareProbabilityRandom AllocationResearchResearch DesignRiskRisk AssessmentTechnology Assessment, BiomedicalTherapeutic Human ExperimentationThird-Party ConsentTime FactorsTreatment OutcomeUncertaintyUnited KingdomBiomedical and Behavioral ResearchHealth Care and Public HealthProfessional Patient RelationshipJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

John D Lantos. 1997. Was the UK collaborative ECMO trial ethical?. https://doi.org/10.1111/j.1365-3016.1997.tb00003.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Cost of cancer care: issues and implications.

Medical technology is increasingly costly in most fields of clinical medicine. Oncology has not been spared from issues related to cost, in part resulting from the tremendous scientific progress that has lead to new tools for diagnosis, treatment, and follow-up of our patients. The increasing cost of health care in general (and cancer care in particular) raises complex questions related to its effects on our economy and the citizens of our society. This article reviews the macroeconomic principles and individual behaviors that govern medical spending, and examines how cost disproportionately affects various populations. Our overall goal is to frame debate about health policy concerns that influence the clinical practice of oncology.

Biomedical Technology↗